This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Stock Market News for September 21, 2016
by Zacks Equity Research
Benchmarks finished slightly higher on Tuesday ahead of the two-day policy meetings of the Fed and Bank of Japan (BOJ) ending today
New Oracle, Gilead Sciences & TOTAL Research Reports
by Sheraz Mian
Today's must-read reports are for Total (TOT), Oracle (ORCL) and Gilead Sciences (GILD).
Stock Market News for August 25, 2016
by Zacks Equity Research
Research Reports for Facebook, DuPont, Gilead & Others
by Sheraz Mian
Today's must-read reports are for DuPont (DD), Facebook (FB) and Gilead (GILD).
Top 7 Research Reports for July 11, 2016
by Sheraz Mian
Today's must-read reports are for Gilead (GILD), Altria (MO) and Qualcomm (QCOM).
Stock Market News for July 07, 2016
by Zacks Equity Research
Benchmarks ended in the green on Wednesday after the FOMC minutes from June meeting showed that most of the Fed policymakers were in favor of keeping rates unchanged.
Top 6 Research Reports for June 29, 2016
by Sheraz Mian
Today's must-read reports are for Amgen (AMGN), Kraft Heinz (KHC) and United Parcel (UPS).
Stock Market News for May 02, 2016
by Zacks Equity Research
Benchmarks closed in the red on Friday following dismal earnings results, which had a negative impact on biotech stocks
5 Biotech Stocks to Bet on This Earnings Season
by Zacks Equity Research
The happening biotech sector should be a good bet for investors.
Making Sense of the Q1 Earnings Reports
by Sheraz Mian
The deceleration in negative estimate revisions could be a positive development on the earnings front.
Stock Market News for March 22, 2012
by Zacks Equity Research
Gains in healthcare and telecom stocks helped the benchmarks end marginally higher on Monday.
Stock Market News for March 16, 2016
by Zacks Equity Research
Benchmarks ended mostly in the red following losses in healthcare and biotech stocks. Further, continuing decline in oil prices also weighed on key U.S. indexes
Best Growth Stocks In The S&P 500
by Brian Bolan
Growth is hard to find in this market, but here is a list of four big caps still growing revenues.
Best Growth Stocks In The S&P 500
by Brian Bolan
Growth is challenged right now, but these large caps are still increasing revenues in a big way.
4 Biotech Stocks Looking Good this Earnings Season
by Zacks Equity Research
the market sentiment seems to be improving driven by upgraded guidance, product approvals and encouraging pipeline updates.
Pharma Industry Outlook: Pricing Pressure and M&As in Focus
by Arpita Dutt
According to a tracking poll, most Americans (72%) find drug costs unreasonable and 74% are of the view that drug companies put profits before people.
Pharma Industry Outlook: Pricing Pressure and M&As in Focus
by Arpita Dutt
According to a tracking poll, most Americans (72%) find drug costs unreasonable and 74% are of the view that drug companies put profits before people.
PEG Ratio vs. the P/E Ratio
by Kevin Matras
Kevin Matras compares the PEG ratio to the P/E ratio and shows how to use them both for finding classically undervalued stocks with market beating growth rates. Highlighted stocks include CALM, EXPR, TSO, BBW and GILD.
What is Your Stock's Earnings Yield?
by Kevin Matras
This week, Kevin Matras talks about a stock's Earnings Yield and how to use it. Highlighted stocks include GILD, GT, KRA, ACM and TNK.
PEG Ratio vs. the P/E Ratio
by Kevin Matras
Kevin Matras compares the PEG ratio to the P/E ratio and shows how to use them both for finding classically undervalued stocks with market beating growth rates. Highlighted stocks include OUTR, GILD, LIOX, SIMO and WNC.
Retail Sector in the Spotlight
by Sheraz Mian
The retail environment is difficult, with consumers hesitant to spend their energy savings.
Retail Sector in the Spotlight
by Sheraz Mian
The retail environment is difficult, with consumers hesitant to spend their energy savings.
R-Squared Growth Rate: You Need to Know This
by Kevin Matras
Kevin Matras writes about the R-Squared Growth Rate and how it can help you find outperforming stocks. Highlighted stocks include GILD, C and BCS.
Standout Sectors of Q1 Earnings Season
by Sheraz Mian
The earnings picture emerging from the Q1 earnings season has been very bad.
Standout Sectors of Q1 Earnings Season
by Sheraz Mian
The earnings picture emerging from the Q1 earnings season has been very bad.